Journal of the American Society of Hypertension

Aims & Scope

Cessation.

The Journal of the American Society of Hypertension (JASH) publishes peer-reviewed articles on the topics of basic, applied and translational research on blood pressure, hypertension and related cardiovascular disorders and factors; as well as clinical research and clinical trials in hypertension.

Original research studies, reviews, hypotheses, editorial commentary and special reports spanning the spectrum of human and experimental animal and tissue research will be considered.

All research studies must have been conducted following animal welfare guidelines.

Studies involving human subjects or tissues must have received approval of the appropriate institutional committee charged with oversight of human studies and informed consent must be obtained.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis

  Citation: 349

  Authors: William L., Lindsay R., Daniel M., Emily M., Kevin W., William B.

• The insular cortex and cardiovascular system: a new insight into the brain-heart axis

  Citation: 274

  Authors: Michiaki, Satoshi, Kazuomi

• Particulate matter, air pollution, and blood pressure

  Citation: 260

  Authors: Robert D., Sanjay

• Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial

  Citation: 239

  Authors: Uta C., Mathias-Christoph, Rolf, Joachim, Lars Christian, Abraham A., Adam W., Eric G., Hermann

• Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis

  Citation: 204

  Authors: Yunan, Xinguang, Kai

• Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial

  Citation: 190

  Authors: George L., Mitra K., Hermann, Eric G., Jill E., John D.

• Blood pressure effects of sodium–glucose co-transport 2 (SGLT2) inhibitors

  Citation: 190

  Authors: Raymond V., George L.

• A content analysis of smartphone–based applications for hypertension management

  Citation: 189

  Authors: Nilay, Monica, Arjun, Neetika

• Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events

  Citation: 176

  Authors: Rhian M., Sandra M.S., Joerg

• Oscillometric blood pressure: a review for clinicians

  Citation: 171

  Authors: Bruce S., David, David